Biotech Investors & VC Firms in Middle East & North Africa
209 firms in this list, with a median first check of $500K. 53 of them lead rounds. Generated from verified public data and updated continuously.
Elaia
ParisSeed–Series C$108K – $1.6M
45 people
Rabo Corporate Venturing
UtrechtSeed–Series B$1.1M – $5.5M
56 people
Kreos Capital
LondonSeries A–Late Stage
43 people
EQT Life Sciences
AmsterdamSeed–Late Stage$11M – $66M
59 people
Big Idea Ventures
MiamiPre-Seed–Seed$200K – $3.5M
15 people
Artesian
SydneyPre-Seed–Growth$20M
41 people
Eight Roads Ventures
MumbaiSeed–Growth$5M – $30M
33 people
Blume Ventures
MumbaiSeed–Series B$50K – $300K
34 people
Seventure Partners
ParisSeed–Growth
19 people
Celesta Capital
San MateoPre-Seed–Series C$5M – $10M
26 people
Metaplanet
TallinnSeed–Series B$500K – $10M
4 people
Hercules Capital, Inc.
San MateoSeries C–Late Stage
51 people
Amadeus Capital Partners
LondonPre-Seed–Growth$50K – $12.7M
28 people
Eurazeo
ParisSeed–Late Stage
35 people
Hyundai Venture Investment Corporation
SeoulSeed–Series B$500K – $2M
b2venture
BerlinPre-Seed–Series B$270K – $5.4M
36 people
ATEL Ventures
San FranciscoSeed–Late Stage
15 people
Hyderabad Angels
HyderabadPre-Seed–Seed$60K – $480K
17 people
M Ventures
AmsterdamSeed–Growth$10.8M
12 people
Supermoon Capital
San FranciscoPre-Seed–Series A$150K – $2.5M
36 people
Primo Ventures
MilanPre-Seed–Growth$1.1M
17 people
Nina Capital
BarcelonaPre-Seed–Seed$215K – $1.6M
24 people
Extantia Capital
BerlinSeed–Series A$1.1M – $5.5M
25 people
Vertex Ventures China
SingaporePre-Seed–Series A
6 people
Related lists
Investors & VC Firms in North America (12910)Investors & VC Firms in United States (11953)Investors & VC Firms in Europe (5849)Investors & VC Firms in Global (4765)AI & Machine Learning Investors & VC Firms (4583)Fintech Investors & VC Firms (4561)SaaS Investors & VC Firms (4227)Healthtech Investors & VC Firms (4206)Enterprise Software Investors & VC Firms (4109)Crypto & Web3 Investors & VC Firms (3976)
Data sourced from public filings and firms' own websites — see our methodology.










































































































